EUVIMEDEUVIMED entdecken
Open Access

RAB22A as a predictor of exosome secretion in the progression and relapse of multiple myeloma

Bingjie Fan, Li Wang, Jishi Wang

Aging · 2024

DOI: 10.18632/aging.205565 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Bingjie Fan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guizhou Province Institute of Hematology, Guizhou Province Laboratory of…. Hauptthemen laut MEDLINE: Multiple Myeloma, Exosomes, Monoclonal Gammopathy of Undetermined Significance. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Multiple myeloma (MM) is an incurable malignant plasma cell disease. We explored the role of RAB22A in exosome secretion, epithelial-mesenchymal transition (EMT) and immune regulation. METHODS: We obtained MM samples from Gene Expression Omnibus (GEO) data sets. We downloaded the "IOBR" package, and used the "PCA" and "ssGSEA" algorithms to calculate the EMT scores and exosome scores. The "CIBERSORT" package was used to analyze the infiltration of immune cells. We extracted the exosomes of mesenchymal stem cell (MSC) to verify the biological function of RAB22A. RESULTS: The expression level of RAB22A in smoldering multiple myeloma (SMM) and MM patients was significantly higher than that in normal people and monoclonal gammopathy of undetermined significance (MGUS) patients, and the expression level of RAB22A in relapse MM patients was significantly higher than that in newly diagnosed patients. The EMT scores and exosome scores of high RAB22A group were significantly higher than those of low RAB22A group, and the exosome scores of MSC in recurrent patients were significantly higher than those of newly diagnosed patients. In addition, the infiltration levels of monocyte, NK cells resting, eosinophils, T cells regulatory and T cells CD4 memory activated were positively correlated with RAB22A. After down-regulating the expression of RAB22A in MM-MSC, the secretion of exosomes decreased. Compared with the exosomes of MSC in si-RAB22A group, the exosomes in control group significantly promoted the proliferation of MM. CONCLUSIONS: RAB22A is a potential therapeutic target to improve the prognosis of MM, which is closely related to exosome secretion, EMT and immune cell infiltration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaExosomesMonoclonal Gammopathy of Undetermined SignificanceHumansPrognosisChronic DiseaseRecurrenceDisease Progressionrab GTP-Binding Proteins

Stichwörter der Autor:innen

EMTRAB22Aexosome secretionimmune regulationmultiple myeloma

Substanzen

RAB22A protein, humanrab GTP-Binding Proteins

Autor:innen und Institutionen

  • Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guizhou Province Institute of Hematology, Guizhou Province Laboratory of Hematopoietic Stem Cell Transplantation Centre, Guiyang, China.
  • Clinical Medicine College of Guizhou Medical University, Guiyang, China.

Zitieren

APA

Fan, B., Wang, L., & Wang, J. (2024). RAB22A as a predictor of exosome secretion in the progression and relapse of multiple myeloma. Aging. https://doi.org/10.18632/aging.205565

Vancouver

Fan B, Wang L, Wang J. RAB22A as a predictor of exosome secretion in the progression and relapse of multiple myeloma. Aging. 2024. doi:10.18632/aging.205565

BibTeX
@article{Fan2024,
  author = {Fan, Bingjie and Wang, Li and Wang, Jishi},
  title = {RAB22A as a predictor of exosome secretion in the progression and relapse of multiple myeloma},
  journal = {Aging},
  year = {2024},
  doi = {10.18632/aging.205565}
}
Kostenlos starten →